Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Integrated Regional Information Networks - September 17, 1999
Parallel meetings at the International Conference on AIDS and STDs in Africa (ICASA) said studies had shown that antiretoviral (AVR) drugs could mitigate the effects of AIDS in sub-Saharan Africa significantly - but that few resources were directed towards such programmes.
They called for increased government and donor support for medical schemes directed at people infected with the HIV-virus. A medical team from C|te d'Ivoire presented a paper that showed that AVRs, if made accessible to the larger population, could slow down the effects of AIDS.
"The results appear to encourage the use of AVR drugs in Africa, as long as they are made genuinely more accessible to patients by subsidising," the team said. A Nigerian medical team, which described AVRs as a "veritable tool" in the management of HIV patients, said the high cost of available drugs was largely responsible for the widespread devastation caused by AIDS.
"The majority of patients can not afford the therapy owing to high cost and unavailability of drugs," it said. The ICASA conference, which began on Sunday and ended on Thursday, saw international aid agencies acknowledging the inadequacy of current AIDS programmes in sub-Saharan Africa were the pandemic has claimed over 11 million lives.
990917
IR990906
Copyright © 1999 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .